Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2022 - 2026)

Kiniksa Pharmaceuticals International (KNSA) has reported Asset Utilization Ratio for 5 consecutive years, with 0.98 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Utilization Ratio rose 16.32% year-over-year to 0.98; the trailing twelve-month figure through Jun 2026 stood at 0.98 (up 16.32% YoY), and the FY2025 full-year result was 1.01, up 31.83% from the prior year.
• Asset Utilization Ratio rose to 0.98 in Q2 2026 per KNSA's latest filing, from 0.95 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.98 in Q2 2026 and bottomed at 0.31 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.66 across 5 years, with a median of 0.62 in 2023.
• The widest YoY moves for Asset Utilization Ratio: up 71.69% in 2023, down 2.61% in 2023.
• Over 5 years, Asset Utilization Ratio stood at 0.48 in 2022, then increased by 11.83% to 0.54 in 2023, then soared by 39.17% to 0.75 in 2024, then advanced by 23.2% to 0.92 in 2025, then rose by 6.41% to 0.98 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.98, 0.95, and 0.92 for Q2 2026, Q1 2026, and Q4 2025 respectively.